Silvant Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,213	Closed	-$87K	–	378
2022 Q2	$87K	Hold	1,213	–	–	0.02%	224
2022 Q1	$119K	Hold	1,213	–	–	0.02%	214
2021 Q4	$103K	Sell	1,213 -78	-6%	-$6.41K	0.02%	221
2021 Q3	$103K	Hold	1,291	–	–	0.02%	220
2021 Q2	$126K	Hold	1,291	–	–	0.02%	215
2021 Q1	$151K	Hold	1,291	–	–	0.03%	202
2020 Q4	$144K	Hold	1,291	–	–	0.02%	209
2020 Q3	$153K	Hold	1,291	–	–	0.03%	193
2020 Q2	$146K	Hold	1,291	–	–	0.03%	194
2020 Q1	$86K	Hold	1,291	–	–	0.02%	205
2019 Q4	$118K	Hold	1,291	–	–	0.02%	213
2019 Q3	$111K	Buy	1,291 +625	+94%	+$58.6K	0.02%	216
2019 Q2	$70K	Hold	666	–	–	0.01%	261
2019 Q1	$83K	Hold	666	–	–	0.01%	241
2018 Q4	$75K	Hold	666	–	–	0.02%	243
2018 Q3	$143K	Buy	666 +185	+38%	+$46.4K	0.02%	212
2018 Q2	$135K	Buy	+481	New	+$84.5K	0.02%	218